These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16223941)

  • 1. In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.
    Piercy T; Steward J; Lever MS; Brooks TJ
    J Antimicrob Chemother; 2005 Dec; 56(6):1069-73. PubMed ID: 16223941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin.
    Steward J; Piercy T; Lever MS; Simpson AJ; Brooks TJ
    Int J Antimicrob Agents; 2006 May; 27(5):439-43. PubMed ID: 16621457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of gatifloxacin, moxifloxacin and ciprofloxacin for treatment of experimental Burkholderia pseudomallei infection.
    Steward J; Piercy T; Lever MS; Nelson M; Simpson AJ; Brooks TJ
    J Antimicrob Chemother; 2005 Apr; 55(4):523-7. PubMed ID: 15731198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolones.
    Steward J; Lever MS; Simpson AJ; Sefton AM; Brooks TJ
    J Antimicrob Chemother; 2004 Jul; 54(1):95-9. PubMed ID: 15163650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
    Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD
    J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection.
    Atkins HS; Spencer S; Brew SD; Laws TR; Thirlwall RE; MacMillan AP; Brooks TJ; Simpson AJ
    Int J Antimicrob Agents; 2009 Nov; 34(5):471-3. PubMed ID: 19682862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.
    Phillips ST; Nagaro K; Sambol SP; Johnson S; Gerding DN
    Anaerobe; 2011 Aug; 17(4):166-9. PubMed ID: 21511046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.
    Steward J; Lever MS; Russell P; Beedham RJ; Stagg AJ; Taylor RR; Brooks TJ
    Int J Antimicrob Agents; 2004 Dec; 24(6):609-12. PubMed ID: 15555886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of ciprofloxacin and doxycycline against experimental tularaemia.
    Russell P; Eley SM; Fulop MJ; Bell DL; Titball RW
    J Antimicrob Chemother; 1998 Apr; 41(4):461-5. PubMed ID: 9598777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Christ D; Gooldy M; Henning LN; Heine HS; Kindt MV; Lin W; Siefkas-Patterson K; Radcliff AK; Tam VH; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fluoroquinolones on mitochondrial function in pancreatic beta cells.
    Ghaly H; Jörns A; Rustenbeck I
    Eur J Pharm Sci; 2014 Feb; 52():206-14. PubMed ID: 24284031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant murine granulocyte colony-stimulating factor with or without fluoroquinolone therapy on mixed-infection abscesses in mice.
    Stearne LE; Vonk AG; Kullberg BJ; Gyssens IC
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3668-75. PubMed ID: 16127038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.
    Alkorta M; Giménez MJ; Vicente D; Aguilar L; Pérez-Trallero E
    Int J Antimicrob Agents; 2005 Feb; 25(2):163-7. PubMed ID: 15664487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
    Scoper SV
    Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice.
    Chacon-Moreno BE; Welsh O; Cavazos-Rocha N; de la Luz Salazar-Cavazos M; Garza-Lozano HG; Said-Fernandez S; Ocampo-Candiani J; Vera-Cabrera L
    Antimicrob Agents Chemother; 2009 Jan; 53(1):295-7. PubMed ID: 18852277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD; D'Azevedo PA; Francisco W
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study investigating the activity of several fluoroquinolones against Pseudomonas aeruginosa using the mutant prevention concentration].
    Sirvent E; Ruiz M; Rodríguez JC; Royo G
    Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):603-7. PubMed ID: 17194384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone.
    Sakalar YB; Ozekinci S; Celen MK
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):593-8. PubMed ID: 21834669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
    Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ
    J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.